Featured Research

from universities, journals, and other organizations

Mouse With Iron Disorder Offers Clues To Parkinson's, Similar Diseases

Date:
February 1, 2001
Source:
NIH/National Institute Of Child Health And Human Development
Summary:
Mice engineered to lack a gene involved in iron metabolism may provide important clues for deciphering the nature of a group of brain disorders — similar to Parkinson's Disease — affecting movement, according to a study by researchers at the National Institute of Child Health and Human Development (NICHD).

Mice engineered to lack a gene involved in iron metabolism may provide important clues for deciphering the nature of a group of brain disorders — similar to Parkinson's Disease — affecting movement, according to a study by researchers at the National Institute of Child Health and Human Development (NICHD). The researchers reported in the February issue of Nature Genetics that mice lacking the gene for iron regulatory protein 2 (IRP2) develop iron deposits in key areas of the brain. The progressive deterioration of the mice's nervous system is like that seen in people with Parkinson's Disease and Multiple System Atrophy (also known as Parkinson's Plus).

"Researchers have long debated whether the characteristic iron deposits of these diseases are the cause or the result of the disease process," said Duane Alexander, M.D., Director of the NICHD. "This is a strong clue that iron may play a causative role in Parkinson's and similar disorders."

Diseases in which excess brain iron has been observed include Parkinson's Disease, Friedreich's Ataxia and Hallervorden-Spatz disease. However, the brain areas affected differ from those in the IRP 2 deficient mice, and it is unlikely that IRP 2 is involved in these human diseases, said the study's senior investigator, Tracey A. Rouault, M.D., of NICHD's Cell Biology and Metabolism Branch. Still, the NICHD finding suggests that other genes involved in iron metabolism may be good candidates for investigations into the causes of these disorders.

In addition, the brain areas affected in the IRP 2 deficient mice correspond closely to those affected in Multiple System Atrophy (formerly known as Olivopontocerebellar Atrophy). For this reason, the NICHD researchers are planning a study to test patients with this disorder for defects of the IRP2 gene.

IRP 2 is a key player in regulating how much iron is in the cell, Dr. Rouault explained. Although iron is a nutrient, too much can also be toxic. For this reason, cells have intricate biochemical machinery to prevent iron from building up to lethal levels. Like its sister protein, iron regulatory protein 1, IRP 2 governs the actions of various other proteins involved in iron metabolism. These include transferrin receptor, which transports iron into the cell; ferritin, which stores iron safely away from the cell's internal machinery; and iron exporters, which ferry iron out of the cell.

Using a method known as "knockout technology," the researchers developed a strain of mice lacking the IRP 2 gene. These mice developed normally at first, then progressively had difficulty walking and moving. Examination of their brains showed that tiny clumps of iron accumulate in the cerebellum, the brain structure controlling movement, and in the basal ganglia, the group of brain cells atop the spinal cord, which assist in movement. These mice also had high blood levels of the iron storage protein ferritin.

"In the corresponding human diseases, you see only the end result," Dr. Rouault said. "With these mice, we know that the primary event is removal of the gene."

Currently, Dr. Rouault is seeking patients with Multiple System Atrophy to take part in a genetic study to learn whether they have a genetic defect involving IRP 2. Similarly, she is also seeking patients with Parkinsonian symptoms for the study, because Multiple System Atrophy often masquerades as Parkinson's. Dr. Rouault and her colleagues are especially interested in seeing patients with these diseases who have relatives with either disorder and have high blood levels of ferritin. Those wishing to participate may have their physicians contact Dr. Rouault at Rouault@mail.nih.gov or write her at the Cell Biology and Metabolism Branch, NICHD, Bldg. 18T, Room 101, Bethesda, MD 20892.


Story Source:

The above story is based on materials provided by NIH/National Institute Of Child Health And Human Development. Note: Materials may be edited for content and length.


Cite This Page:

NIH/National Institute Of Child Health And Human Development. "Mouse With Iron Disorder Offers Clues To Parkinson's, Similar Diseases." ScienceDaily. ScienceDaily, 1 February 2001. <www.sciencedaily.com/releases/2001/01/010131074233.htm>.
NIH/National Institute Of Child Health And Human Development. (2001, February 1). Mouse With Iron Disorder Offers Clues To Parkinson's, Similar Diseases. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2001/01/010131074233.htm
NIH/National Institute Of Child Health And Human Development. "Mouse With Iron Disorder Offers Clues To Parkinson's, Similar Diseases." ScienceDaily. www.sciencedaily.com/releases/2001/01/010131074233.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins